🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer

RecruitingNAAges 18 Years - anyAllOhio State University Comprehensive Cancer Center
NCT03711890 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This trial studies how well ultra-high resolution optical coherence tomography works in detecting micrometer sized early stage pancreatic cancer in participants with pancreatic cancer. Ultra-high resolution optical coherence tomography may help to accurately identify pancreatic cancer in resected pancreatic specimens.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Immediate surgery cohort: Adult patients with pancreatic cancer or IPMN * Immediate surgery cohort: Informed consent will be obtained * Adult patients undergoing pancreatic resection for a presumed IPMN Exclusion Criteria: * Pregnant
💊

What it tests

  • Optical Coherence Tomography
  • Therapeutic Conventional Surgery
  • Laboratory Evaluation
📍

Where

1 site
Ohio State University Comprehensive Cancer Center
Columbus, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy